CRWD extended its October 23 breakout on October 26, closing at $261.83 (+1.65%, +$4.26) on 8.20M shares - 0.96x the 20-day average of 8.58M and 0.84x the 60-day average of 9.76M - for a second consecutive close above the ($255.81), with a session high of $264.39 that has now cleared the $263.87 September 24 high. The tape was friendlier: fell 5.45% to 18.39 from 19.45, the Nasdaq rose 0.82%, the S&P 500 0.70% and the Dow 0.28%, while the 10-year held at 4.99%. Internal repair continued - the line is now positive at 1.2725, the histogram narrowed a fourth straight session to -1.550 from -6.720 on October 20, (14) advanced to 57.76 from 55.92, and rose 8.20M to 196.68M - though the line remains below its 2.8224 signal and is still 15.97% below the October 6 peak of 234.06M. Volume is the soft spot: the follow-through came on below-average volume versus 13.37M on the breakout session, so the move is confirmed by price but not yet by participation. Long-term structure remains unambiguous - price is 10.38% above the ($237.20) and 47.76% above the ($177.20) - and the stock still sits 8.77% below its $286.99 high. Fundamentals are unchanged and strong: 25.8% revenue growth, a 75.19% gross margin, $1.995B of free cash flow, $5.01B of cash against $820.18M of debt, six beats in six supplied quarters averaging a 5.94% surprise, and FY estimates showing 48 upward versus 1 downward revision over the past 30 days. Valuation is the problem and the rally made it worse: the forward is 162.50x on next-year of $1.61123, price-to-sales 49.68x, 6.65, price-to-book 52.54x and the free-cash-flow yield 0.74%, while the $247.25 mean and $250 median targets now sit 5.9% and 4.7% BELOW spot. No article in the bundle is newer than September 30 - the Falcon-in-OpenAI-Marketplace listing remains the only identifiable fundamental catalyst and still carries no disclosed bookings - and the event_calendar fields are null, so the December 1 report referenced in the prior snapshot (roughly 36 days out) is the next scheduled test. The stance stays HOLD with a modestly higher score of 55: BUY for one month on the confirmed follow-through, HOLD for six months into the next print, and SELL for one year because at 162.5x forward earnings a full year of ~28% growth is already discounted and any multiple normalization produces a negative twelve-month return. Key levels are $255.81 and $246.36 below and $264.39, $268.95 and $286.99 above.
Decision
Live price
$261.83
Recommendation score
55%
55%
Confidence
62%
62%
Outlook by horizon
1M
BUY
Near
6M
HOLD
Mid
1Y
SELL
Long
Primary catalyst
The Falcon listing in the OpenAI Marketplace (September 30) remains the single most market-moving fundamental item because it is the only plausible catalyst that could organically justify a 162.50x forward multiple - it puts Falcon directly inside the procurement workflow of OpenAI's enterprise customers and, per the source article, ties security spend to budgets already committed for frontier models. The catch is that no bookings, revenue, joint-customer counts, sales-cycle changes or AI-focused deal sizes have been disclosed, so the next scheduled opportunity to quantify it is the upcoming earnings report; until management breaks that out, the actual driver of the current 10.0% two-session move is unexplained flow rather than news.
Decision Workspace
Price Map
60-day setup
Price rail
$261.83
Stop
Now
$238
$256
$274
$292
Stop loss
$242.00
Entry
$250.00 - $258.00
Exit
$272.00 - $287.00
Risk / reward
2.1x
Favorable
Downside to stop
-7.6%
Upside to exit
+9.6%
Position sizing
Keep exposure at half-normal size or less inside a Satellite Upside sleeve, and do not chase the $261.83 close. The breakout is legitimate and now confirmed by a second session - a fresh $264.39 high, a second close above the $255.81 and a fourth straight session of histogram improvement - but the entry is 5.57% above the consensus mean target with an of $12.72 (4.86% of price) and 20-day realized volatility at 55.9%, so risk per unit of reward is materially worse here than on a retest toward $250-$258. The next report is roughly 36 days away by the prior snapshot's date; any position carried into it must be sized for a 10%+ gap, which on a ~5% stock is routine.
Thesis Snapshot
Why It Works
The October 23 breakout was confirmed rather than faded, and that is the strongest argument for owning CRWD here. The stock added 1.65% on October 26 to $261.83 after gaining 8.25% on October 23, printing a fresh session high of $264.39 that cleared the $263.87 September 24 high and holding a second consecutive close above the rising $255.81 - roughly 10.0% of cumulative recovery from the $237.94 October 22 close in two sessions, with the October 26 low of $254.06 never threatening the breakout pivot. It happened in a supportive but not euphoric tape ( -5.45% to 18.39, Nasdaq +0.82%, S&P 500 +0.70%, 10-year flat at 4.99%) and momentum keeps improving: the line is positive at 1.2725, the histogram has now narrowed four consecutive sessions to -1.5498 from -6.7200 on October 20 (a 77% closure of the gap), (14) is at 57.76 and rising without being overbought, and has added 21.56M since the October 22 trough to 196.68M. The long-term structure was never broken - price is 47.76% above the at $177.20 with the 33.86% above it. And the franchise keeps beating: 25.8% revenue growth, a 75.19% gross margin, $1.995B of free cash flow, $4.19B of net cash, six beats in six supplied quarters averaging 5.94%, 48 upward versus 1 downward FY revision over 30 days, and a target ladder from Mizuho at $275 to Freedom Broker at $320. If the flow persists, the $268.95-$270.04 zone is the next stop and the Street has to chase it.
What Breaks It
The strongest argument against owning CRWD is that the entire 10.0% two-session advance has no identifiable catalyst in the supplied news - the newest article is dated September 30 - and the second leg came on declining volume (8.20M versus 13.37M, only 0.96x the 20-day average and 0.84x the 60-day). Flow that arrives unexplained in a stock with 55.9% realized volatility can leave the same way. Everything that made the stock expensive on October 22 is still true, only more so: the forward is now 162.50x on next-year of $1.61123, current-year about 208.3x on $1.25679, price-to-sales 49.68x against a cited Software-industry average near 3.7x, 6.65 and a free-cash-flow yield of 0.74%. A full year of expected ~28.2% growth is already in the price, so the stock is flat in twelve months if the multiple merely holds; a derating to 140x implies $226 (-13.8%), 125x about $201 (-23.1%) and 110x about $177 (-32.3%), all with estimates unchanged. The consensus has been left further behind rather than vindicated - the $247.25 mean and $250 median now sit 5.57% and 4.73% BELOW spot, versus 4.24% and 2.94% on October 23 - so the sell side must raise targets to validate a price it did not forecast. Fundamental momentum is not accelerating: FY26 is still 1.8% below its 60-day level and 2.0% below its 90-day level, FY27 1.2% below its 60-day level, GAAP operating margin is -2.26%, and the OpenAI Marketplace contribution is entirely undisclosed. Technically the confirmation is incomplete: the histogram is still negative at -1.5498 with the line below its 2.8224 signal, 57.76 is only mid-range, and at 196.68M remains 15.97% below the October 6 peak of 234.06M, so the September-October distribution has not been absorbed. And the December 1 report - roughly 36 days out per the prior snapshot, though the current bundle's event_calendar is null - is a binary on a stock where one is $12.72.
A daily close below $255.81 (the ) would be the first warning that the two-day advance is failing; a daily close below $246.36 - the October 22 high broken on October 23 - would mark the whole move as a one-day squeeze rather than a change of character and put the $237.20 back in play, and a close below that would confirm resumption of the October 7-22 downtrend and reopen $228.70 and $221.36. On the upside, the thesis is validated by a close above the $268.95-$270.04 September congestion on volume at or above 13.3M shares with pushing back toward the October 6 peak of 234.06M, which would open the $286.99 52-week high and force the $275-$325 target cluster into play.
Multiple compression: forward 162.50x on next-year of $1.61123, current-year about 208.3x, price-to-sales 49.68x, 6.65, price-to-book 52.54x, roughly 2,429x and a 0.74% free-cash-flow yield; a rerating to 140x implies roughly $226 (about 13.8% below the $261.83 close), 125x about $201 (about 23.1% below) and 110x about $177 (about 32.3% below), in every case with estimates unchanged.
Unconfirmed participation and reversal risk: the two-session 10.0% advance has no dated catalyst in the bundle, the second leg came on 0.96x the 20-day average volume, at 196.68M is still 15.97% below the October 6 peak of 234.06M, short interest is 2.60% of float with a 2.26-day short ratio and no historical short series is supplied - so squeeze mechanics cannot be distinguished from genuine accumulation.
Estimate and execution risk: revenue is growing 25.8% but current-year of $1.25679 is 1.8% below its 60-day level and 2.0% below its 90-day level, GAAP operating margin is -2.26%, the OpenAI Marketplace bookings, revenue and customer counts remain undisclosed, and the next report (cited as December 1, 2026 in the prior snapshot, roughly 36 days away, with this bundle's event_calendar null) must defend a 162.50x forward multiple that consensus targets no longer bracket.
Macro and rate risk: the 10-year Treasury at roughly 4.99% sits near the top of its recent range and is the direct lever on a 162.50x multiple, while with beta of 1.197, 20-day realized volatility of 55.9% and at 4.86% of price ($12.72) a single adverse session can move the shares $13 or more - enough to erase the entire $255.81-to-$246.36 support shelf.
Watch Next
The Falcon listing in the OpenAI Marketplace (September 30) remains the single most market-moving fundamental item because it is the only plausible catalyst that could organically justify a 162.50x forward multiple - it puts Falcon directly inside the procurement workflow of OpenAI's enterprise customers and, per the source article, ties security spend to budgets already committed for frontier models. The catch is that no bookings, revenue, joint-customer counts, sales-cycle changes or AI-focused deal sizes have been disclosed, so the next scheduled opportunity to quantify it is the upcoming earnings report; until management breaks that out, the actual driver of the current 10.0% two-session move is unexplained flow rather than news.
Signal Dashboard
Decision inputs
6 signals
Fundamental
-5.6%
Upside to analyst mean target
At $261.83 the trailing of 4,363.8x is not decision-useful given a 0.834% net profit margin, and even the current-year multiple of roughly 208.3x on FY26 of $1.25679 is extreme. The decision-useful number is the forward of 162.50x measured on next-year consensus of $1.61123 - and it rose again from 159.86x on October 23 purely because the price gained another 1.65%, on an otherwise unchanged fundamental base. That means a full year of expected ~28.2% growth ($1.25679 to $1.61123) is already embedded: if the multiple merely holds at 162.50x the stock is flat in twelve months, and any positive return requires further multiple expansion from an already extreme level. A rerating to 140x next-year implies roughly $226 (-13.8%), 125x about $201 (-23.1%) and 110x about $177 (-32.3%), in every case with estimates unchanged. Price-to-sales of 49.68x compares with the roughly 3.7x Software-industry average and 14.9x peer-group average cited in the September 30 Simply Wall St article, though those benchmarks are indicative rather than a fully matched peer study; is 6.65, more than 4x the customary 1.5x growth-stock reference; price-to-book is 52.54x. of about 2,429x is economically uninformative at a 1.98% margin. Enterprise value of $259.58B against a $268.10B market cap (0.97x) shows the $4.19B net cash position is immaterial to equity value - it equals just 1.56% of market capitalization - and a 0.74% free-cash-flow yield offers essentially no valuation support if growth or margin progress stalls. Simply Wall St's community split of 11% undervalued against 76% overvalued captures the disagreement, and the more important fact is that the $247.25 mean target now sits 5.57% BELOW spot. No reliable historical-multiple series or fully matched peer set is supplied, so this is a judgment call rather than a mechanical conclusion - but the judgment is that current profitability does not validate the premium, and two consecutive up sessions made the gap wider.
Technical
Bullish
Trend quality
The October 26 session confirmed rather than reversed the October 23 change of character. CRWD closed at $261.83, up 1.65% (+$4.26) from $257.57, for a second straight close above the at $255.813 (now 2.35% above a rising 20-day) and a session high of $264.39 that cleared the $263.87 September 24 high - the first layer of the September congestion. The stock opened at $258.53, dipped only to $254.06 (holding above the and far above the $234.79 post-breakout low) and closed in the upper quarter of a $10.33 range. Overhead resistance now sits at the $268.95 September 30 high and the $270.04 October 2 close, with the $286.99 52-week high 9.6% above spot. The long-term structure was never in question: price is 10.38% above the at $237.203 and 47.76% above the at $177.203, while the sits 33.86% above the , so the golden cross remains firmly intact. The setup is now an intact bull market pressing back into the September supply zone rather than a distribution pattern.
Earnings
Open
Improving
For the July 31, 2026 quarter, of $0.31 beat the $0.29141 consensus by 6.38%; across the six supplied quarters the average surprise is roughly 5.94%, though the pattern is uneven - 10.62% in April 2025 and 12.05% in July 2025 compressed to 1.98% and 1.56% in the October 2025 and January 2026 quarters before recovering to 3.05% and then 6.38%. Caveats: only six quarters are supplied rather than eight, the April 2025 $0.73 observation is an outlier versus adjacent quarters ($0.2325 in July 2025), annual consensus dollars remain 1.8% below their 60-day level, and the bundle's event_calendar is entirely null (no next_earnings_date, no days_to_next_earnings, no recent_earnings_dates), so the durability of this beat pattern into the next report - cited as December 1, 2026 in the prior snapshot, roughly 36 days away - cannot be independently verified from this run's data.
News
Mixed-Bullish
Headline tone
The Falcon listing in the OpenAI Marketplace (September 30) remains the single most market-moving fundamental item because it is the only plausible catalyst that could organically justify a 162.50x forward multiple - it puts Falcon directly inside the procurement workflow of OpenAI's enterprise customers and, per the source article, ties security spend to budgets already committed for frontier models. The catch is that no bookings, revenue, joint-customer counts, sales-cycle changes or AI-focused deal sizes have been disclosed, so the next scheduled opportunity to quantify it is the upcoming earnings report; until management breaks that out, the actual driver of the current 10.0% two-session move is unexplained flow rather than news.
Macro
Neutral
4.99% 10Y / 18.4 VIX
fell 5.45% to 18.39 - still inside the 15-20 Neutral band - and the 10-year held at 4.99%, so the discount-rate drag on a 162.5x forward-multiple name is unchanged, but the broader bid (Nasdaq +0.82%, S&P 500 +0.70%) let CRWD extend its breakout, meaning idiosyncratic flow and falling volatility are currently offsetting rather than reversing the rate headwind.
Stability
High-Beta Growth
Satellite Upside
CrowdStrike pairs a durable enterprise-cybersecurity franchise - 25.8% year-over-year revenue growth, a 75.19% gross margin and $1.995B of free cash flow against only $820.18M of debt - with a valuation governed entirely by the multiple rather than by reported earnings: forward 162.50x on next-year of $1.61123, current-year about 208.3x on $1.25679, price-to-sales 49.68x, 6.65, price-to-book 52.54x, roughly 2,429x and a -2.26% GAAP operating margin. The $4.19B net cash position equals only 1.56% of the $268.10B market cap, so it cushions but cannot anchor the price. The equity is structurally volatile - 55.9% 20-day realized volatility, a $12.72 (4.86% of price), beta 1.197 and a $23.12 single-session range on October 23 - so 5-8% daily moves are normal behavior rather than anomalies. It belongs in a smaller Satellite Upside sleeve sized so that a 30%+ sentiment-driven drawdown is survivable, and with a 0.0% dividend yield and a 0.74% free-cash-flow yield it cannot be relied on for income or downside defense.
Analyst Spread
Mean Target
$247.25
High / Low
$132 / $325
Median Target
$250.00
Consensus range
$132 - $325
— analysts
Mean
$132$247$325
Consensus
The October 26 close of $261.83 is now 5.57% ABOVE the $247.25 mean target and 4.73% above the $250.00 median - the stock has overshot consensus by more than it had on October 23, so the sell side must revise rather than defend. The $325 high target implies 24.1% upside while the $132 low implies roughly 49.6% downside, an unusually wide spread of $193, or about 73.7% of the current price, signalling genuine disagreement about what multiple the business deserves. The rating tally is 10 Strong Buy, 30 Buy, 12 Hold, 0 Sell and 1 Strong Sell across 53 ratings and has barely moved in three months (10/31/11/0/1 at -3m), but the separately reported number-of-analysts field for price targets is null. A bullish rating mix paired with a mean target below spot is the classic signature of stale ratings lagging a fast-moving price - it is neither a fresh endorsement nor a warning on its own, but consensus-implied upside can no longer be cited as support.
Positioning Pulse
Insider Signal
Neutral
Net Bias
No recent activity
Insider Own.
1.4%
Institutional Own.
77.9%
Interpretation
The supplied record establishes neither discretionary buying, discretionary selling, nor 10b5-1 activity, so it carries no reliable directional signal about management's confidence, and the absence of any meaningful Form-4 activity should be treated as information-free rather than as a bullish or bearish tell - which is especially relevant after a two-session 8.4% advance ($237.94 on October 22 to $261.83) that insiders were evidently not trading into.
Notable activity
The extract contains a single record: Director Laura J. Schumacher, 39 shares, direct ownership. Transaction type is blank and value_usd is null, and the date field reads only '149', so the entry cannot be classified as a purchase or a sale. At the $261.83 close that position is worth roughly $10,211 - immaterial whatever the direction, and far too small to register against a $268.10B market capitalization.
Market Context
Industry
Software - Infrastructure
Mixed-Bullish
Sentiment
20
Tracked names
10
Grouping
industry
Software - Infrastructure industry is currently Mixed-Bullish with an average recommendation score near 54. capital and conviction are improving across the group, and leadership is concentrated in MSFT, PLTR, ORCL.
Rotation Drivers
Average recommendation deltas are trending higher across Software - Infrastructure industry, which suggests improving risk appetite inside the group.
1 names are rated bullish versus 1 bearish names, keeping the group tone mixed-bullish.
Leadership is concentrated in MSFT, PLTR, ORCL, so those names are the cleanest read on group-level capital rotation.
The relevant sector is Software - Infrastructure, specifically enterprise cybersecurity wrapped around increasingly common enterprise AI workflows. The OpenAI Marketplace listing and the reported Tamnoon and Salt integrations strengthen both distribution and product-use-case breadth, and Morgan Stanley's September 30 Okta note explicitly frames agentic identity as the next growth vector, evidence the narrative has reached the buy side. The October 23-26 advance suggests capital is willing to pay up for the theme again, but none of it is yet quantified: the supplied article itself frames the test as whether management breaks out Marketplace-driven wins or reports shorter sales cycles and larger AI-focused deal sizes, and none of that exists in the bundle. The theme is strengthening narratively while its contribution to estimates remains speculative - two up sessions showed it can carry the stock back through the and into the September supply zone, but not that it can justify 162.50x forward earnings on its own.
Falcon's placement inside the procurement workflow of OpenAI enterprise customers, combined with the buy side's new focus on agentic identity, has put AI-agent security back at the center of cybersecurity positioning with the next earnings report now the only scheduled venue for disclosure.
Eligible OpenAI enterprise customers can apply a portion of existing OpenAI commitments toward Falcon procurement, linking security spend to an already-funded AI budget rather than requiring a new line item.
The next earnings report - cited as December 1, 2026 in the prior snapshot, roughly 36 days away, though the current bundle's event_calendar is null - is the next scheduled venue for disclosure on Marketplace-sourced bookings, joint-customer growth or AI-focused deal sizes, making it the natural catalyst for the theme.
The only dated company-specific analyst actions in the bundle are all price-target increases with ratings maintained (Mizuho, Keybanc, Citigroup, Freedom Broker, BTIG, Wells Fargo), so conviction is being expressed through targets rather than through fresh initiations.
Long-Duration Software De-Rating
Score: -30
Mixed-Bearish
CRWD remains one of the most duration-sensitive large caps with a 162.50x forward , 49.68x price-to-sales and a 6.65 , and the October 26 tape was less hostile than October 23 - fell 5.45% to 18.39, the Nasdaq rose 0.82% and the S&P 500 0.70%, while the 10-year held at 4.99% - yet the multiple still expanded because the stock rose 1.65%. That is the key evidence: the multiple is no longer trading on the discount rate but on stock-specific flow, which cuts both ways - it can ignore a flat-to-rising yield on the way up and ignore a falling yield on the way down. De-rating pressure still caps the re-rating potential until either earnings inflect or sentiment toward long-duration software improves materially, and two up sessions made the starting multiple higher, not lower.
The 10-year Treasury at roughly 4.99% remains near the top of its recent range while CRWD's forward multiple rose to 162.50x from 159.86x in one session on no fundamental news, so the gap between the discount rate and the multiple being paid has widened again.
CRWD closed 5.57% above its $247.25 mean consensus target and 4.73% above the $250 median, so sell-side upside must be revised upward before it can be cited as support again.
Morgan Stanley's September 30 Okta note describes investor interest broadening toward Okta and Fortinet, with SentinelOne and SailPoint considered in some cases, framing CRWD's roughly 50x sales multiple as a relative-value hurdle rather than a default allocation.
of 6.65, price-to-book of 52.54x and a 0.74% free-cash-flow yield leave no valuation-based floor if estimate momentum stalls.
Key Stats
23 metrics total
Market Cap
$268.10B
P/E (TTM)
4363.8
Forward P/E
162.5
Revenue Growth
25.8%
ROE
1.5%
Beta
1.20
Full Metric Set
17 additional stats
Valuation Stack
Multiples and cash-flow framing.
Price / Sales
49.7
Price / Book
52.5
EV / EBITDA
2429.1
Quality & Balance Sheet
Margins, leverage, and liquidity.
Gross Margin
75.2%
Operating Margin
-2.3%
Debt / Equity
16.0
Current Ratio
1.57x
Quick Ratio
1.37x
Positioning & Range
Short interest and 52-week location.
Short % Float
2.6%
Short Ratio
2.26x
52W High
$286.99
52W Low
$85.68
From 52W High
-8.8%
From 52W Low
205.6%
Company Classification
Sector and industry context.
Sector
Technology
Industry
Software - Infrastructure
Additional Signals
Free Cash Flow
$1995385472.00
Detailed Analysis
Valuation
At $261.83 the trailing of 4,363.8x is not decision-useful given a 0.834% net profit margin, and even the current-year multiple of roughly 208.3x on FY26 of $1.25679 is extreme. The decision-useful number is the forward of 162.50x measured on next-year consensus of $1.61123 - and it rose again from 159.86x on October 23 purely because the price gained another 1.65%, on an otherwise unchanged fundamental base. That means a full year of expected ~28.2% growth ($1.25679 to $1.61123) is already embedded: if the multiple merely holds at 162.50x the stock is flat in twelve months, and any positive return requires further multiple expansion from an already extreme level. A rerating to 140x next-year implies roughly $226 (-13.8%), 125x about $201 (-23.1%) and 110x about $177 (-32.3%), in every case with estimates unchanged. Price-to-sales of 49.68x compares with the roughly 3.7x Software-industry average and 14.9x peer-group average cited in the September 30 Simply Wall St article, though those benchmarks are indicative rather than a fully matched peer study; is 6.65, more than 4x the customary 1.5x growth-stock reference; price-to-book is 52.54x. of about 2,429x is economically uninformative at a 1.98% margin. Enterprise value of $259.58B against a $268.10B market cap (0.97x) shows the $4.19B net cash position is immaterial to equity value - it equals just 1.56% of market capitalization - and a 0.74% free-cash-flow yield offers essentially no valuation support if growth or margin progress stalls. Simply Wall St's community split of 11% undervalued against 76% overvalued captures the disagreement, and the more important fact is that the $247.25 mean target now sits 5.57% BELOW spot. No reliable historical-multiple series or fully matched peer set is supplied, so this is a judgment call rather than a mechanical conclusion - but the judgment is that current profitability does not validate the premium, and two consecutive up sessions made the gap wider.
Balance Sheet
Total cash of $5.01B covers $820.18M of debt about 6.11x, leaving approximately $4.19B of net cash; debt-to-equity is only 15.96% and operating-cash-flow-to-debt is 2.46x. Operating cash flow of $2.017B is nearly equal to free cash flow of $1.995B, evidencing high cash conversion and very low capital intensity. Current and quick ratios of 1.57 and 1.37 are adequate for a software platform carrying deferred revenue. The caveat is scale and returns: $4.19B of net cash equals only about 1.56% of the $268.10B market capitalization, so it cushions but cannot offset a 162.50x forward earnings multiple, and reported returns remain weak with of 1.46% and of -0.78%.
Growth
Revenue growth of 25.8% year over year remains strong at this scale and is the core support for the premium multiple. The July 2026 quarter's $0.31 of was roughly 33% above the $0.2325 reported a year earlier, and the sequential path excluding the anomalous April 2025 $0.73 print reads 0.2325, 0.24, 0.28, 0.275, 0.31 - a rising trajectory. Annual consensus is still not improving in absolute terms: current-year of $1.25679 is 1.8% below its 60-day level of $1.27992 and 2.0% below its 90-day level of $1.2818, while next-year of $1.61123 is 1.2% below its 60-day level of $1.63018 and 1.0% below its 90-day level of $1.62848. Gross margin is high at 75.19%, but GAAP operating margin remains negative at -2.26% and margin is only 1.98%, so operating leverage has yet to appear in reported profitability. The bundle's earnings_growth_yoy field is null and no quarterly revenue or margin time series is supplied, so margin-expansion direction cannot be verified from the data.
Business Quality
CrowdStrike's 75.19% gross margin, roughly $2.0B of trailing free cash flow and entrenched position in enterprise endpoint, cloud and identity security underpin real pricing power and platform quality. That quality is offset by a -2.26% GAAP operating margin, a 1.98% margin, a 0.834% net profit margin, 1.46% and -0.78% , which make current reported returns a thin foundation for the prevailing multiple. Liquidity is sound with current and quick ratios of 1.57 and 1.37. Institutional ownership is 77.87% and insider ownership 1.35%; short interest is 2.60% of float with a 2.26-day short ratio, implying neither a crowded short nor a durable squeeze setup, and because no historical short series is supplied it is impossible to tell whether bearish conviction is building. is 1.197 and 20-day realized volatility is 55.9%, so the equity is materially more volatile than the market before valuation risk is even considered. The franchise supports a premium multiple; these profitability metrics do not validate the full premium.
Capital Allocation
CrowdStrike is self-funding with $5.01B of cash, $820.18M of debt and nearly $2.0B of trailing free cash flow, and enterprise value of $259.58B versus a $268.10B market cap (0.97x) confirms that net cash is immaterial relative to equity value. The company pays no dividend (0.0% yield and 0.0% payout ratio) and therefore offers no shareholder-yield cushion against multiple compression. Shares outstanding are approximately 1.024B with a float of 1.008B, but the bundle provides no share-count time series and no detailed buyback data, so dilution or repurchase intensity cannot be evaluated and returns on specific recent capital deployments cannot be assessed. The overall read is that investment can be fully internally funded, but capital allocation is not currently delivering a material offset to valuation risk.
Estimate Revisions
Revision breadth remains strongly positive even though annual consensus dollars sit below where they were 60 and 90 days ago. Over the last 30 days, current-year shows 48 upward versus 1 downward revision and next-year 42 up versus 4 down; near-term quarters are less one-sided at 16 up versus 11 down for the current quarter and 25 up versus 11 down for the following quarter, and the quarterly trend lines are modestly higher over 90 days ($0.31146 versus $0.31040 for the current quarter, $0.35708 versus $0.35323 for the next). Sell-side price targets kept rising into and after the breakout: Mizuho to $275 from $250 (October 22), Keybanc to $265 from $245 (October 16), Citigroup to $295 from $260 (October 15), Freedom Broker to $320 from $260 and BTIG to $312 from $245 (October 14), with Wells Fargo to $300 from $235 on October 13. Yet annual dollars remain 1.8%/1.2% below their 60-day levels, the bundle records zero formal upgrades, zero downgrades and zero initiations over the last 90 days, and the consensus mean has only drifted to $247.25 from $246.65 - still below spot. The hikes reflect multiple tolerance and conviction rather than an upward reset in earnings power.